Singulair Safety Division Of Labor: In Search For Suicide Data, Merck Will Scan Studies While FDA Tackles Post-marketing Reports
Executive Summary
Merck and FDA are working on parallel tracks to investigate a possible link between its asthma product Singulair (montelukast) and suicidality
You may also be interested in...
DDMAC To Cornerstone: Zyflo CR Promotions Need Current Safety Labeling
An FDA advertising violation letter for Cornerstone Therapeutics' asthma therapy Zyflo CR should serve to remind industry that providing outdated safety labeling with promotions is a sure way to draw the agency's regulatory scrutiny
DDMAC To Cornerstone: Zyflo CR Promotions Need Current Safety Labeling
An FDA advertising violation letter for Cornerstone Therapeutics' asthma therapy Zyflo CR should serve to remind industry that providing outdated safety labeling with promotions is a sure way to draw the agency's regulatory scrutiny
Class Labeling For Anti-epileptics Embraces Lessons From Antidepressants
Anti-epileptic drug sponsors have until mid-January to decide whether to fight FDA-mandated labeling changes and a REMS program after a meta-analysis showed a statistically significant increase in suicidality.